BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
LUND, Sweden, May 1, 2012 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that it has been selected as a Top 100 Winner for Red Herring's 2012 Europe Award, a prestigious list honoring the year's most promising private technology ventures from the European business region. BONESUPPORT was one of only nine winners within the healthcare categories.
"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across Europe to the Top 100 Winners. We believe BONESUPPORT embodies the vision, drive and innovation that define a successful entrepreneurial venture. BONESUPPORT should be proud of its accomplishment, as the competition was the strongest it has ever been."
The Red Herring editorial team selected a short list of 247 companies to compete as 2012 winners after assessing the most innovative companies from a pool of hundreds from across Europe. The Top 100 Europe winners were evaluated on quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and disruption in their respective industries.
This unique assessment of potential is complemented by a review of the actual track record and standing of a company, which allows Red Herring to see past the 'buzz' and make the list a valuable instrument for discovering and advocating the greatest business opportunities in the industry.
"Our business has recently shifted from a research and development focus to a fully commercial and multi channeled business," said Lloyd Diamond, CEO of BONESUPPORT. "I am pleased that our efforts and our innovative technology have been recognized in this way. As one of only nine companies within the Healthcare categories to win an award, we are extremely proud."
For more information about BONESUPPORT and CERAMENT, visit www.BONESUPPORT.com.
About Red Herring
Red Herring is a global media company uniting the world's best high-technology innovators, venture investors, and business decision-makers in a variety of forums: a leading innovation magazine, an online daily technology news service technology newsletters, and major events for technology leaders around the globe. Red Herring provides an insider's view of the global innovation ecosystem, featuring unparalleled insights on the emerging technologies driving the economy.
BONESUPPORT is an emerging leader of injectable bone substitutes for orthopedic trauma focusing on bone infection, instrument augmentation related to orthopedic surgery and spinal applications. CERAMENT™ is a fully developed product platform that is commercially available in the U.S. and Europe and is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT spans more than eleven years and over forty-five pre-clinical, clinical and animal studies have been conducted. More than 4,000 patients have been treated with CERAMENT. The company was founded in 1999 and is based in Lund, Sweden with subsidiary locations in the US and Germany. To learn more about BONESUPPORT please visit www.bonesupport.com.
Fredrik Groth, CFO, +46 46 286 53 60, Fredrik.Groth@bonesupport.com
More by this Source
Protokoll der Studie CERTiFy (CERAMENT™|Tibia Fracture) in TRIALS veröffentlicht
Mar 12, 2014, 11:30 ET
CERTiFy (CERAMENT™|Tibia Fracture) Study Protocol Published In TRIALS
Mar 12, 2014, 09:30 ET
Le protocole de l'étude CERTiFy (CERAMENT™|Tibia Fracture) est publié dans TRIALS
Mar 12, 2014, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.